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Abstract
 .Recent studies indicate that the actions of arginine vasopressin AVP and other agonists that stimulate electrogenic
sodium transport in renal epithelial A6 cells are linked to a Ca2q-mobilizing signal transduction mechanism that involves
generation of inositol trisphosphate. Since diacylglycerol is the other product in this pathway, studies were performed to
determine the possible role of PKC in the stimulation of sodium transport. AVP induced a biphasic increase in
diacylglycerol generation, characterized by an initial rapid rise and then a sustained elevation, and PKC activation, reflected
 .by phosphorylation of a specific 80 kDa myristoylated alanine-rich PKC substrate MARCKS . To determine the PKC
 .isoform s involved in this process, immunoblot analysis was performed using antisera that recognize both classical PKC
isoforms, XPKC-I and XPCK-II, cloned from Xenopus oocytes. The transcripts of both isoforms were expressed in the A6
cell. Since protein recognized by antisera was translocated from cytosol to the particulate fraction after exposure to AVP,
one or both isoforms were activated in the A6 cell. Further studies showed that cyclohexyladenosine and insulin, additional
agonists of sodium transport in A6 cells, also stimulated phosphorylation of MARCKS. These results argue that
Ca2q-dependent PKC is involved in the action of AVP, and that of other agonists, which stimulate sodium transport. q 1998
Elsevier Science B.V.
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1. Introduction
Electrogenic sodium transport by epithelial cells is
limited by sodium conductance of the apical cell
membrane, which is modulated by sodium channels
) Corresponding author. Fax: q1-203-785-7068; E-mail:
john.hayslett@yale.edu
w x1–3 . Following the recent cloning of the subunit
w xproteins that form this channel 4,5 , important in-
sights have been provided into its biochemical struc-
w x  .ture and topology 6 . The mechanism s that regulate
agonist-stimulated upregulation of apical membrane
conductance, however, is less well defined.
Recent studies have shown that multiple agonists,
including AVP, stimulate electrogenic sodium trans-
port in the A6 cell, derived from the kidney of
Xenopus lae˝is, by a common signal transduction
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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w xsystem 7–10 . This system involves turnover of
 .phosphatidylinositol 4,5-bisphosphate PIP and re-2
lease of Ca2q from intracellular stores due to the
action of inositol 1,4,5-trisphosphate. Since diacyl-
 .glycerol DAG , the natural activator of protein ki-
 .nase C PKC , is the second product of PIP hydroly-2
sis, it seemed possible that PKC was an active partic-
ipant in upregulation of the system that mediates
sodium transport. Using AVP as the model physio-
logical agonist, the present study was performed to
determine whether hormonal action involves PKC
 .activation, and to examine which class of isoform s
may be involved.
2. Experimental
2.1. Materials
 .Arginine vasopressin AVP , phorbol 12 myristate
 .  .13-acetate PMA , dimethyl sulfoxide DMSO , pro-
tein A Sepharose CL4B and protease inhibitors were
 . 32w xobtained from Sigma St. Louis, MO . P -ortho-
phosphoric acid was supplied by Amersham Arlin-
.gton Heights, IL . Chelerythrine was from Alomone
 .Laboratories Jerusalem, Israel . The ECL kit was
 .purchased from Dupont NEN Boston, MA . Rabbit
antiserum raised against a purified bovine brain
MARCKS protein was kindly provided by Dr. Angus
Nairn, Rockefeller University. Rabbit antisera di-
rected against conserved regions in C1 and C2, or the
kinase domain including C3 and C4 of rat brain
w xPKC-g 11 were kindly supplied by Prof. Yasuo
Fukami, Kobe University, Kobe, Japan. The peptide
sequences selected from rat brain PKC-g were ho-
mologous with the sequences in XPKC-I and PKC-II
w xcloned from Xenopus oocytes 12 . Full length cDNA
for both isoforms were provided by Dr. H.F. Kung,
NIH Cancer Institute. All other reagents were of
highest grade available.
2.2. Cell culture
Experiments were performed on a clone of A6
 .cells A6S2 derived from X. lae˝is. The methods
employed for cell culture have been described else-
w xwhere 8,9 . Briefly, experiments were performed on
cells grown to confluence on porous Falcon mem-
 .branes Beckton-Dickenson, Bedford, MA with an
active surface area of 4.5 cm2 after 10 to 14 days of
subculture at 268C, when these cells form a mono-
layer of fully differentiated epithelial cells with maxi-
mum electrical resistance. These conditions were the
same as those employed in previous studies where
sodium transport was measured.
2.3. Diacylglycerol measurement
AVP, 1 mM, was added to the basal media of
monolayers. After various times of exposure to AVP,
media was rapidly aspirated from both sides of mono-
layers, and the reaction was terminated by addition of
1 ml ice-cold methanol to the cells. The methanol
was then transferred to a tube containing 1 ml of
CHCl , and 0.8 ml of 0.2% SDS was added to3
solubilize the cells. The extract of cells was trans-
ferred to the tube containing the CHCl . Finally, any3
portion of extract still adherent to the membrane was
collected in a second wash with 1 ml ice-cold
methanol, which was also combined with the sample.
Samples were vortexed for 30 s, placed on ice for 1
to 2 h, vortexed again after addition of another 1 ml
of CHCl and 1 ml of 0.2 M NaCl, and finally3
centrifuged for 5 min at 900=g to permit recovery
of the lower phase containing lipids. The lipid extract
was dried and stored under N atmosphere at y708C2
until the assay was performed.
Neutral lipids were extracted from the N stored2
w xsamples, as previously described 13,14 , and DAG
content was determined using a modification of the
w xDAG kinase method of Preiss et al. 15 .
2.4. 32P-labelling and incubations
Cells were washed twice with a phosphate free
amphibian Kreb’s Ringer buffer 110 mM NaCl, 3
mM KCl, 1 mM CaCl , 0.5 mM MgCl , 5 mM2 2
.glucose and 10 mM HEPES, pH 7.4 and incubated
32 with 100 mCirml P specific activity, ;200i
.mCirmmol for 3 h at 268C. Previous studies have
shown that 32P, added in trace amounts, achieves
equilibrium with the cellular pool of ATP within 2 h
w x16 . After labelling, cells were washed with serum-
free culture medium three times and incubated with
agonists as indicated in the figure legends. Reactions
were terminated by replacing the medium with 0.8 ml
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ice-cold lysis buffer 10 mM Tris, 10 mM NaCl, 20
mM NaF, 20 mM NaPP , 1 mM ZnSO , 0.5% Tritoni 4
.X100, 0.5 mgrml saponin, pH 7.4 containing 2 mM
AEBSF, 125 mM leupeptin, 100 mM chymostatin,
and 25 mgrml aprotinin. Cells were kept on ice for 5
min, scraped off with a rubber policeman and cen-
trifuged for 1 min in a microcentrifuge. Supernatants
were used to extract MARCKS by immunoprecipita-
tion with anti-MARCKS antibody.
2.5. Isolation and identification of MARCKS
Previous studies in this laboratory demonstrated
w xthat MARCKS is present in the A6 cell 17 . Evi-
dence was provided showing an 80-kDa protein,
phosphorylated after exposure to PMA, isolated by
w xthe acid extraction method 18,19 , and by immuno-
precipitation with an antibody raised against MAR-
w xCKS in bovine brain 20 . In addition, exposure to
these bands to S. aureus V8 protease yielded a
doublet of 13 and 9 kDa bands, characteristic of
w xauthentic MARCKS protein 20 . In the present study,
MARCKS was isolated by immunoprecipitation after
intact A6 monolayers grown on permeable mem-
branes were exposed to physiological agonists, or
PMA used as a positive control.
Aliquots of A6 cell lysates were pre-cleared in a
 .suspension of Pansorbin cells Calbiochem and incu-
bated overnight at 48C with a 1:25 dilution of anti-
MARCKS antiserum. After exposure to Protein A
conjugated Sepharose-CLUB beads, samples were
washed and boiled in SDS sample buffer. After cen-
trifugation, the supernatant was applied to SDS-PAGE
and autoradiography.
2.6. Northern blot analysis
Total RNA was isolated from A6S2 cells grown on
porous cell culture membranes 10 days after seeding.
 .qCells were lysed in TriZol reagent. Poly A RNA
was purified using an mRNA isolation system from
 .Promega Madison, WI , as described by the manu-
 .qfacturer. Poly A RNA was electrophoresed on a
1.2% agaroserformaldehyde gel and transferred to a
Nylon membrane Hybond-N, Amersham, Arlington
.Heights, IL .
Two pUC18 plasmids, containing full length cD-
 .  .NAs of X. lae˝is PKC-I 2.1 kb and PKC-II 2.2 kb
cDNA respectively, were kindly provided by Chen et
w xal. 12 . The plasmids were propagated in XLI-Blue
E. coli cells and isolated using a Maxiprep kit
 .Qiagen . The sequence of PKC inserts were con-
 .firmed. A 929-bp PCK-I XbaI I-929 bp fragment
 .and a 666-bp PKC-II 1626–2292-bp BamHI frag-
 .ment were isolated using Gel Extraction Kit Qiagen ,
and radiolabeled with 32P by random oligonucleo-
tide-primed synthesis for Northern analysis. Hy-
bridization conditions were 50% formamide, 5= SSC
1= SSC is 0.15 M NaCl and 0.015 M sodium
. citrate, pH 7.0 , 5= Denhardt’s solution 1= Den-
hardt solution is 0.1 g Ficoll 400, 0.1 g
polyvinylpyrrolidone and 0.1 g bovine serum albumin
.in 500 ml H 0 , 1% SDS and 100 mgrml denatured2
salmon sperm DNA, at 428C. Nylon membranes were
washed in 2= SSC containing 0.1% SDS at 428C
and exposed at y708C.
2.7. Protein kinase C translocation studies
A6 cells grown as monolayers on Falcon mem-
branes were stimulated with 300 nM PMA or 1 mM
AVP for the indicated times at 268C. After incuba-
tion, reactions were stopped by washing the cells
quickly with 1 ml ice-cold 5 mM EGTA in PBS, pH
 .7.4. Buffer 200 ml containing 60 mM Tris–HCl,
pH 7.4, 10 mM EGTA, 2 mM EDTA, 10 mM 2
mercaptoethanol and a cocktail of protease inhibitors,
as described above, was then added to each culture
cup. Cells were lysed by repeated freezing and thaw-
ing in dry ice and methanol for three cycles. Cytoso-
lic and membrane fractions were separated by cen-
trifugation for 5 min at 100 000=g, in a refrigerated
 .Beckman Instruments airfuge. Pellets were resus-
pended in 200 ml of the homogenization buffer con-
taining 1% Triton X100. Aliquots of the cytosolic
and membrane fractions were mixed with equal vol-
umes of 2= SDS sample buffer, boiled for 5 min,
and processed for SDS-PAGE and immunoblotting
with isoform specific antisera.
2.8. SDS-PAGE, immunoblotting and autoradio-
graphy
Slab gel electrophoresis was performed at constant
 .current 30 mA for approximately 5 h using a
Laemmli buffer system. Gels were stained with either
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Coomassie blue or silver stain, dried and autoradio-
graphed to visualize 32P orthophosphate-labeled pro-
teins. For immunoblotting, gels were electrophoreti-
cally transferred onto nitrocellulose membranes using
a BioRad wet transfer apparatus and the Towbin
buffer system. Nitrocellulose membranes were stained
with Ponceau Red to visualize the proteins. For im-
munostaining with PKC antibodies, blots were incu-
bated as follows: 1% BSA in PBST, 1 h; PKC
 .antibodies 1:1000 dilution in 1% BSA and PBST, 2
 .h; PBST PBS with Tween 20 for 15 min three
times; HRPO-conjugated goat anti-rabbit IgG Hq
.L , 1:1000 dilution in 1% BSA and PBST; PBST for
15 min three times. An enhanced chemiluminescence
 .ECL detection system was used according to the
manufacturer’s instructions to visualize the im-
munoreactive bands.
3. Results
3.1. AVP-stimulated production of diacyglycerol
Since previous studies demonstrated that the signal
transduction mechanism mediating AVP stimulation
of sodium transport in A6 cells involves PIP hydrol-2
w xysis and generation of inositol trisphosphate 9 , we
sought to determine whether diacylglycerol produc-
tion was also stimulated. Fig. 1 demonstrates that a
 .Fig. 1. Effect of AVP on generation of diacylglycerol DAG :
time-dependent elevation of A6 cell DAG content by 1 mM
vasopressin. These data are representative of two separate experi-
ments, each containing two samples at each time point. The DAG
 .content was determined with Imagequant 3.1 software on a
 .phosphoimager Molecular Dynamics, Sunnyvale, CA , and data
are expressed in arbitrary units, representing the integrated area
32w xof the P -labeled DAG samples. Values are mean"range.i
rapid increase in cellular DAG content occurred after
addition of AVP, reaching a maximum level at ap-
proximately 5 to 10 s. The initial peak was followed
by a second phase of sustained elevation for at least
30 min.
3.2. AVP-stimulated phosphorylation of MARCKS
After identification of MARCKS protein in A6
w xcells 17 , we sought to determine whether vaso-
pressin caused detectable PKC activation, using
MARCKS phosphorylation as the marker of activa-
tion. After ATP pools of A6 cell monolayers were
labeled with 32P orthophosphate, cells were exposed
to 1 mM AVP for various times. PMA, a pharmaco-
logical activator of PKC, was also used at 300 nM as
a positive control. MARCKS was then immunopre-
cipitated and analyzed by SDS-PAGE and auto-
radiography.
As shown in the autoradiograph in Fig. 2A, phos-
phorylation of the 80-kDa protein was increased both
by PMA and AVP, suggesting that AVP indeed
induced PKC activation. AVP-induced phosphoryla-
tion, presumably by PKC, was demonstrated within 1
min of agonist exposure and persisted for at least 1 h,
corresponding to the time course of vasopressin stim-
w xulation of sodium transport 9 . By densitometry,
phosphorylation was increased above control after
exposure to PMA by 70%, and after exposure to AVP
by 27%, 1 min; 27%, 10 min; 32%, 30 min; and 20%
after 60 min. To verify the identity of the 80-kDa
band obtained in AVP-treated samples as MARCKS
protein, the 80-kDa bands from control and AVP-
treated cells were reprocessed on 15% SDS-PAGE in
the presence of S. aureus V8 protease. Fig. 2B shows
that 13 and 9 kDa peptides, characteristic of authentic
w xMARCKS proteins 20–22 , were generated from
both samples.
3.3. Expression of PKC-I and PKC-II in A6 cells
Since two isoforms that resemble classical PKC
were identified in Xenopus oocytes, further experi-
ments were performed to determine whether PKC-I
and PKC-II were expressed in A6 cells. Northern blot
analyses were performed with PKC-I and PCK-II
cDNA probes. Fig. 3 shows that both PKC isoforms,
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 . 32w x  .Fig. 2. Effect of AVP on MARCKS phosphorylation: A P -labeled A6 cells were stimulated with either PMA 300 nM, 5 min ori
 .AVP 1 mM, for the times indicated . Cell lysates were immunoprecipitated with the MARCKS antibody and visualized by
autoradiography following SDS PAGE. Arrow shows the position of the 80-kDa protein that is phosphorylated in response to either PMA
 .and AVP. Note that AVP stimulated phosphorylation persists for 60 min. Data shown are representative of four experiments. B S.
aureus V8 proteolysis of the 80 kDa protein phosphorylated in response to AVP yields the characteristic MARCKS pattern identical to
that of the control protein.
 .corresponding to 2.1 kb XPKC-I and 2.2 kb
 .XPKC-II were identified and therefore expressed in
A6 cells.
3.4. AVP-stimulated translocation of PKC
Translocation of PKC from soluble to particulate
portions of the cell characterizes the activation of
some classes of PKC isoforms and may serve to
 .identify the isoform s involved in an individual bio-
logical response. Immunoblotting experiments were
therefore performed with antisera that recognize the
two distinct isoforms of PKC identified in the A6 cell
w x11 to determine whether they are activated by AVP.
Fig. 4 shows that exposure of A6 cells to PMA
resulted in an increase of an 80-kDa protein located
in the particulate fraction as recognized by antisera
raised against the C region of classical isoforms in2
Xenopus. It is likely that the immunoreactive 80-kDa
protein represented PKC because it migrated on SDS
gels closely with rat brain PKC, used as a marker,
and because it translocated to the particular fraction
upon exposure to PMA. Similar results were obtained
Fig. 3. Northern blot analysis of PKC-I and PKC-II expression in
A6S2 cells. Expression of PKC-I and PKC-II in A6 cells was
investigated by Northern blot. Molecular mass is indicated on the
left. Membranes were hybridized using PKC-I and PKC-II cDNA
probes and washed in 2= SSC containing 0.1% SDS.
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Fig. 4. Effect of AVP on PKC translocation: A6 cells were
stimulated with 300 nM PMA or 1 mM AVP as indicated. Cell
 .homogenates were separated into cytosolic S and particulate
 .  .membrane P fractions as described in Section 2. A The
immunoblot was probed with a C2 domain-specific PKC anti-
body that recognizes an 80-kDa protein in A6 cells co-migrating
 .with the rat brain PKC arrow . Note that both PMA and
vasopressin stimulate the translocation of the 80-kDa protein
from the cytosol to the membrane fraction. Data shown is
 .representative of four experiments. B Densiometric analysis of
the particulate membrane fraction that compares experimental
conditions to control.
with antisera that recognize the C1 and kinase re-
gions of PKC, although immunoreactions were less
 .intense data not shown .
Fig. 4 also demonstrates that AVP-induced PKC
translocation from soluble to the particulate fraction,
indicating PKC activation. The data shown are repre-
sentative of one of four experiments. This response
was evident at 1 min and persisted for at least 30
min, as shown in experiments involving MARCKS
protein phosphorylation. Densitometric analysis
showed that PMA increased the immunoreaction in
the particulate fraction by 70%. AVP increased the
immunoreaction in the particulate fraction by 24% at
1 min, 28% at 5 min and 40% at 30 min. This result
therefore suggests that AVP activates at least one or
both of the classical PKC isoforms identified in
Xenopus; classical isoforms are characterized by a C2
functional domain that is thought to represent the
Ca2q binding site, and includes isoforms a-, b- and
-g in mammals.
( )3.5. Action of cyclohexyladenosine CHA and insulin
on PKC acti˝ation
Besides AVP, the adenosine analogue CHA, which
preferentially binds to the A -receptor, and insulin1
stimulate electrogenic sodium transport in the A6 cell
by a signal transduction mechanism that involves
turnover of phosphatidylinositol 4,5-bisphosphate
Fig. 5. Effect of other sodium transport agonists and a PKC
antagonist on MARCKS phosphorylation: 32P -labeled A6 cellsi
were stimulated for 5 min as follows: insulin, 1 mM; cyclohexy-
 .ladenosine CHA , 1 mM; AVP, 1 mM with or without 15 min
 .preincubation with 5 mM chelerythrine Chele ; PMA, 300 nM.
Phosphorylation and immunoprecipitation of MARCKS were car-
ried out as described under Section 2. Arrow indicates the
position of MARCKS protein. Data shown are representative of
two experiments. Densitometric analysis of the depicted autora-
diograph is shown, and is expressed as in Fig. 4.
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w x8,10 . Further studies were therefore, performed to
determine whether these cell surface binding agonists
also activated PKC, reflected by phosphorylation of
MARCKS.
A representative autoradiograph and densitometric
measurements are shown in Fig. 5. Compared to
control, CHA and insulin increased phosphorylation
of MARCKS by 43% and 23%, respectively. Phos-
phorylation increased by 79% with PMA and 26%
with AVP, and were similar to the experiment shown
in Fig. 2. Fig. 5 also shows that preincubation of cells
with 5 mM of the highly specific PKC inhibitor
chelerythrine abolished AVP-stimulated phosphoryla-
w xtion. Since chelerythrine was shown 9 to dose-de-
pendently inhibit agonist-stimulated sodium transport
in A6 cells with a K ;1 mM, a value similar to thati
observed with the isolated enzyme, these results ar-
gue that chelerythrine-induced inhibition of sodium
transport was caused by PKC inhibition.
4. Discussion
The present study was designed to determine
whether AVP activates PKC in the A6 cell, which
has been used extensively as a model of distal nephron
epithelial cells to study electrogenic sodium transport.
A second messenger role for PKC in upregulation of
sodium transport is supported by two previous find-
 .ings: 1 AVP induced PIP hydrolysis, reflected by2
 .the generation of inositol trisphosphate, and 2 inhi-
bition of sodium transport dose-dependently by dif-
ferent classes of highly specific antagonists of PKC
w x9 . Since diacylglycerol, the natural agonist of PKC,
is the second product of PIP hydrolysis, an increase2
in diacylglycerol mass and PKC activation seemed
likely.
The present study confirms an AVP-induced rise
in diacylglycerol levels. The rapid initial increase in
diacylglycerol levels has been shown in other cells to
w xresult from phosphatidylinositol breakdown 23 . In
contrast, the sustained elevated levels for greater than
10 min may imply other sources for generation of
diacylglycerol, such as phosphatidylcholine and phos-
 w x.phatidic acid reviewed in Ref. 23 . Further studies
using isotopically labeled phospholipids will be re-
quired to establish the origin of diacylglycerol at
early and late phases of production and are currently
underway.
MARCKS is a specific endogenous substrate for
w xPKC 24 . The use of MARCKS as a phosphorecep-
tor therefore, provides a specific assay for the en-
dogenous activity of PKC when activated by physio-
logical agonists, in contrast to the traditional in vitro
assay that employs histones that are not specific for
w xPKC 25 . Moreover, AVP-induced phosphorylation
of MARCKS shows that the 80-kDa protein is in-
volved in the transduction pathway activated by this
agonist. Since MARCKS is known to link F-actin to
the plasma membrane and appears to regulate dy-
w xnamic changes in the cytoskeleton 26 , its phospho-
rylation by AVP suggests that the action of AVP may
result in alterations of the cytoskeleton.
The demonstration that PKC is translocated from
cytosol to a membrane fraction, in contrast, provides
indirect evidence of PKC activation, but also can
identify PKC-isoforms involved in a reaction when
antibodies are raised against a class of isoforms or
specific isoforms. The antibodies used in the present
immunoblot experiments were reported to identify
two different PKCs in Xenopus which, on the basis
of structural and functional characteristics, resemble
w xPKC a and b isoforms found in rat brain 11 .
Exposure of A6 cells to AVP resulted in rapid
phosphorylation of MARCKS protein in vivo within
1 min, corresponding to the rapid rise in IP , Ca, the3
onset of sodium transport observed in a previous
w xstudy 9 , and the AVP-induced increase in diacyl-
glycerol levels in the present study. In addition, these
studies show that increased levels of diacylglycerol
and PKC activation both persisted for at least 30 to
60 min after exposure to AVP, suggesting that PKC
activation may be involved in the sustained action of
the hormone. In A6 cells, the AVP stimulated in-
crease in sodium transport persists for several hours
w x9 .
The increase in PKC-induced phosphorylation of
MARCKS of about 25 to 30% corresponds to the
range of phosphorylation previously reported in other
intact cells using physiological stimuli, as judged by
inspection of immunoblots or estimates made from
w xdensitometry 27,28 . The action of PMA caused
about a twofold increase in phosphorylation, as in
w xother reports when large doses are used 29 . The
greater immunoreaction due to PMA may reflect
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maximal stimulation of multiple isoforms of PKC,
which, in contrast to the natural agonist diacylglyc-
w xerol, are not rapidly downregulated 30 .
The demonstration that exposure to AVP resulted
in translocation of PKC to a membrane fraction
suggests that one or both of the classical PKC-iso-
forms previously identified in the Xenopus oocyte
and expressed in the A6 cell are involved in the
transduction pathway activated by AVP. The anti-
serum used in this study reacts with the C region of2
the enzyme, a region which confers Ca2q sensitivity
and one which is implicated in the capacity to
translocate to membranes upon an increase in Ca2q.
These results, however, do not exclude a possible
role for other PKC-isoforms in the transduction path-
way.
Evidence derived from previous studies in this
laboratory that suggest that PKC activation serves to
upregulate sodium transport are contrary to earlier
reports. Application of phorbol esters to the apical
w xmembrane of A6 cells 31 , or phorbol esters or DAG
analogues to the basolateral membrane of rabbit dis-
w xtal nephron 32 , inhibited basal and AVP-stimulated
sodium transport. More recent studies, however, did
not detect an inhibition of sodium transport when
cortical collecting tubules from DOC-treated rats were
exposed to PMA or the synthetic DAG analogue
w xOAG 33 . In other studies in contrast, phorbol esters
and DAG analogues were reported to stimulate
w xsodium transport in frog skin 34 . Interpretation of
these studies, is unclear, however, since phorbol es-
ters and DAG analogues stimulate multiple PKC
isoforms that may have effects unrelated to the signal
transduction pathway of interest. Moreover, their ac-
tion, unlike that of native DAG, are not susceptible to
feedback mechanisms that control dephosphorylation
w xof PKC. 30 . Recent reports indicate that the physio-
logical implications of phobol ester-induced biologi-
cal responses should be interpreted with caution
w x35,36 .
5. Conclusion
Together, these studies indicate that vasopressin
and other agonists of electrogenic sodium transport
cause activation of PKC in the A6 cell. They also
indicate that chelerythrine-induced inhibition of
sodium transport correlates with inhibition of PKC
phosphorylation. Furthermore, they suggest that one
or more calcium-dependent PKC isoforms cloned in
Xenopus are messengers in the transduction pathway
that subserves stimulation of hormone-stimulated
sodium transport.
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